Related references
Note: Only part of the references are listed.Menopause and aging Changes in the immune system-A review
Catia Morgado Gameiro et al.
MATURITAS (2010)
Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases
Hiroyuki Oka et al.
HEART AND VESSELS (2008)
Chronic inflammation and oxidative stress in human carcinogenesis
Alessandro Federico et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Changes in serum cytokine concentrations during the menopausal transition
Toshiyuki Yasui et al.
MATURITAS (2007)
Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor κB transactivation
H Liu et al.
CYTOKINE (2005)
The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure
S von Haehling et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)
Plasma cytokine profiles in elderly humans
RJ Forsey et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2003)
Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet
C Napoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Age-related inflammatory cytokines and disease
H Brüünsgaard et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance
SE Shoelson et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
KJ Kallen
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
Genetic and environmental influences on IL-6 and TNF-α plasma levels in apparently healthy general population
I Pantsulaia et al.
CYTOKINE (2002)
Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation
LJ Roberts et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women
D Rachon et al.
JOURNAL OF ENDOCRINOLOGY (2002)
Cytokine production by stimulated mononuclear cells did not change with aging in apparently healthy, well-nourished women
N Ahluwalia et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Age-related reduction of NO availability and oxidative stress in humans
S Taddei et al.
HYPERTENSION (2001)
Aging and proinflammatory cytokines
H Bruunsgaard et al.
CURRENT OPINION IN HEMATOLOGY (2001)
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause
C Scheidt-Nave et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes
N Giuliani et al.
EXPERIMENTAL GERONTOLOGY (2001)
Postmenopausal changes in serum cytokine levels and hormone replacement therapy
M Kamada et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Cytokines and bone loss in a 5-year longitudinal study - Hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study
B Abrahamsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
PM Ridker et al.
CIRCULATION (2000)
Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: Effects of oxidation and modulation by lovastatin
ZA Massy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
